1984: Thread

grarpamp grarpamp at gmail.com
Thu Sep 15 22:12:12 PDT 2022

Adderall Shortage Worsens As People Without Drug "Not Able To Focus",
May Impact Productivity


Adderal supplies in the US are dwindling as pharmacies and patients
report shortages. The crux of the problem appears to be a major
supplier of the drug for attention deficit/hyperactivity disorder has
run into supply chain issues. Patients who find themselves without
their medication might experience "withdraw" or even a "crash" that
could impact productivity at work.

The supply crunch first hit our radar last month when the National
Community Pharmacists Association found hundreds of pharmacies across
the US had trouble purchasing Adderall and generic versions of the
brand in late July.

Bloomberg spoke with a dozen patients in California, Indiana, and
Michigan who were told by their local pharmacists at CVS Health Corp.
or Walgreens Boots Alliance Inc. about a worsening drug shortage.

    "In some cases, patients were told they might have to wait more
than a week to get their medication, which is supposed to be taken
every day," Bloomberg noted.

Walgreens spokesperson Rebekah Pajak acknowledged that "supply chain
challenges" persist with the drug. She said instant-release and
extended-release Adderall are the ones in the shortest supply.
Meanwhile, CVS spokesperson Matthew Blanchette said Adderall
prescriptions at the company's pharmacies can be filled "in most

The shortage began at Teva Pharmaceuticals, the US' largest branded
and generic Adderall supplier. Blomberg noted the Israeli
multinational pharmaceutical company experienced "labor shortages"
that led to the limited supply of brand-name and generic
instant-release Adderall. Then three other companies Amneal
Pharmaceuticals Inc., Rhodes Pharmaceuticals LP, a subsidiary of
Purdue Pharma LP, and Novartis AG's Sandoz unit, all were hit with a
surge in orders for generic extended-release Adderall that is now on
"back order."

What appears to have happened in the world of pharmaceuticals is that
when one drug manufacturer has a problem, it quickly has a ripple
effect across the industry.

The shortage comes as amphetamine sales are at record highs, driven by
increased ADHD diagnoses. During the virus pandemic, the federal
government eased rules requiring patients to see a doctor in-person
before the controlled substance was prescribed which is one of the
contributing factors to over-prescription.

For those who miss their daily dosage because of the shortage, it's
entirely possible to experience symptoms of Adderall withdrawal. Some
describe it as a "crash" that can leave people drowsy for hours, if
not days, and include symptoms of mental and physical exhaustion and
feelings of depression.

    Anthony Anderson, a 34-year-old special education teacher at a
Michigan high school, said he has been without his Adderall since
Sept. 6. He's been taking the medicine for 15 years to treat his ADHD,
and without it, he says it's incredibly difficult to concentrate,
which makes it challenging for him to do this job. Sometimes, he
forgets what he is talking about mid-sentence.

    Anderson was recently talking with a student about a suicide at
the school, and at a time when he was supposed to be helping the
grieving student, he just couldn't pay attention.

    "I even spaced out when I'm trying to have a serious conversation
with this girl to console her, but I spaced out because I'm not able
to focus," he said. "This is a huge issue for me." -Bloomberg

We would love to see the productivity metrics of performance-based
companies over the next several months to see how an Adderall shortage
impacted productivity. Then again, Wall Street has the luxury of
another stimulant if an Adderall shortage affects Manhattan
pharmacies; that is cocaine.

More information about the cypherpunks mailing list